DB
PFE icon

Dmitry Balyasny’s Pfizer PFE Stock Holding History

Dmitry Balyasny’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$50.5M Buy
2,098,400
+735,600
+54% +$19.2M 0.06% 358
2026
Q1 		$38.3M Sell
1,362,800
-157,300
-10% -$4.19M 0.05% 429
2025
Q4 		$37.9M Sell
1,520,100
-430,600
-22% -$10.9M 0.05% 445
2025
Q3 		$49.7M Buy
1,950,700
+578,100
+42% +$14.3M 0.06% 367
2025
Q2 		$33.3M Buy
1,372,600
+938,500
+216% +$21.9M 0.05% 463
2025
Q1 		$11M Buy
434,100
+394,400
+993% +$10.3M 0.02% 863
2024
Q4 		$1.05M Sell
39,700
-2,859,100
-99% -$77.6M ﹤0.01% 1930
2024
Q3 		$83.9M Buy
2,898,800
+2,873,500
+11,358% +$83.8M 0.14% 164
2024
Q2 		$708K Sell
25,300
-1,376,400
-98% -$37.9M ﹤0.01% 1923
2024
Q1 		$38.9M Sell
1,401,700
-14,300
-1% -$397K 0.07% 393
2023
Q4 		$40.8M Sell
1,416,000
-4,670,000
-77% -$141M 0.08% 324
2023
Q3 		$202M Buy
6,086,000
+4,695,000
+338% +$166M 0.41% 32
2023
Q2 		$51M Buy
+1,391,000
New +$54.1M 0.11% 247
2022
Q1 		– Sell
-280,000
Closed -$16.5M – 2758
2021
Q4 		$16.5M Buy
+280,000
New +$13.9M 0.06% 489
2021
Q3 		– Sell
-20,000
Closed -$783K – 2313
2021
Q2 		$783K Sell
20,000
-80,000
-80% -$3.11M ﹤0.01% 1394
2021
Q1 		$3.62M Hold
100,000
– – 0.02% 816
2020
Q4 		$3.68M Sell
100,000
-4,959,200
-98% -$182M 0.02% 738
2020
Q3 		$176M Buy
5,059,200
+2,635,000
+109% +$92.4M 1.29% 1
2020
Q2 		$75.2M Buy
+2,424,200
New +$82.4M 0.65% 16
2017
Q4 		– Sell
-1,633,700
Closed -$55.3M – 2243
2017
Q3 		$55.3M Buy
+1,633,700
New +$52.5M 0.22% 111
2015
Q3 		– Sell
-122,053
Closed -$3.88M – 1325
2015
Q2 		$3.88M Sell
122,053
-931,947
-88% -$30.4M 0.02% 649
2015
Q1 		$34.8M Buy
+1,054,000
New +$33.5M 0.28% 99

Other funds holding PFE

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Dmitry Balyasny's PFE Position: Q2 2026 in Review

Dmitry Balyasny reduced its Pfizer (PFE) stake by 92% in Q2 2026, selling an estimated $251M and leaving 857,605 shares worth $20.7M. The position accounts for 0.03% of the portfolio, ranked #703.

Dmitry Balyasny first reported a position in PFE in Q4 2014 and has held it in 42 quarters since. The position peaked at $294M in Q1 2026. 2,818 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • Dmitry Balyasny held 857,605 shares of Pfizer worth $20.7M as of Q2 2026.
  • Dmitry Balyasny sold 9,613,783 Pfizer shares in Q2 2026, an estimated $251M.
  • Pfizer made up 0.03% of Dmitry Balyasny's portfolio in Q2 2026, its #703 holding.
  • Dmitry Balyasny first reported a position in Pfizer in Q4 2014 and has held it in 42 quarters since.
  • Dmitry Balyasny's Pfizer position peaked at $294M in Q1 2026.
  • 2,818 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Balyasny Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.